BIOMET 3i is expanding its dental implant product portfolios with a series of distribution deals and focusing its products in new strategic kits.
Three new product distribution agreements along with forthcoming new product launches will allow BIOMET 3i to commercialize a series of strategic system solutions which will include Sustainable Aesthetics, Full Arch Rehabilitation and Peri-Implant Health Management, according to a press release.
The new distribution deals include an agreement for BIOMET 3i to sell the ZEST LOCATOR Overdenture Implant System for less invasive surgery when there is limited bone volume; NeoBiotech’s Implant Removal Kit which is designed for atraumatic removal of implants from multiple systems when peri-implant complications arise; and the final deal will be for marketing and distribution of a forthcoming product being developed by Dr. Stephen Chu, Dr. Mark Hochman and Adam Mieleszko.
View Full Press Release
BIOMET 3i Announces New Strategic Portfolio Products as it Unveils its Solutions Strategy
Palm Beach Gardens, Fla. - BIOMET 3i is pleased to announce that it has secured rights to distribute new strategic portfolio products in order to deliver new multiple technology system solutions designed to help clinicians achieve optimal patient care.
- BIOMET 3i has signed an agreement to distribute the ZEST LOCATOR® Overdenture Implant (LODI) System, which provides a less-invasive alternative for patients who have limited bone volume, but still desire dental implant retained partial or full arch prostheses.
- The company has also secured an agreement with Dr. Stephen Chu, Dr. Mark Hochman and Adam Mieleszko to market and distribute a patented and innovative product designed for aesthetics that is in the main stream of its development.
- Finally, BIOMET 3i has agreed to distribute NeoBiotech’s Implant Removal Kit, which is designed specifically for dental implant placers who encounter peri-implant complication cases requiring removal of an implant from an infected site. The removal kit will allow users to atraumatically remove implants from multiple implant systems so that the clinician can consider retreatment with an implant designed to mitigate peri-implantitis (for example, the 3i T3® Implant).
BIOMET 3i President, Bart Doedens, explains that these new portfolio products, together with a series of planned new technology introductions, will allow the company to focus on commercializing the following strategic system solutions: Sustainable Aesthetics, Full Arch Rehabilitation and Peri-Implant Health Management.
“We are taking the right steps to align ourselves with the treatment solutions our customers need and want for their patients,” says Doedens. “It is no longer just about the ‘products’ you sell. Our doctors want solutions so that they can better treat their patients who continue to expect faster, longer lasting, and aesthetically optimal treatment. We are focused on the entire solution and not just the bits and pieces. There’s more to implant dentistry than that.”